TVTX Competitors & Alternatives
Compare Travere Therapeutics Inc with similar stocks in the same industry
Biotechnology
TVTX
Main Stock$55.89
Tradestie Score
59
Market Cap
$2.21B
Revenue Growth
0.6%
Analyst Upside
+5.8%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.55
|
$6.03B | - | 54 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$47.99
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 57 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$217.99
|
$5.92B | - | 54 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$52.03
|
$5.80B | 18.7 | 60 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$341.12
|
$5.20B | 49.0 | 59 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$54.08
|
$4.94B | - | 48 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$68.01
|
$4.93B | - | 57 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$84.65
|
$4.84B | - | 60 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More TVTX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry